Skip to main content
Erschienen in: Clinical Rheumatology 12/2007

01.12.2007 | Original Article

Association of tri-nucleotide (CAG and GGC) repeat polymorphism of androgen receptor gene in Taiwanese women with refractory or remission rheumatoid arthritis

verfasst von: S. F. Yu, T. T. Cheng, Y. H. Hsu, H. M. Lai, Y. C. Chen, C. K. Chiu, K. M. Lin, C. Chang, C. J. Chen, H. Y. Kang

Erschienen in: Clinical Rheumatology | Ausgabe 12/2007

Einloggen, um Zugang zu erhalten

Abstract

We investigated the relationship between CAG and GGC repeat polymorphism of the androgen receptor (AR) gene and rheumatoid arthritis (RA) in female patients with different disease subtypes. This case-control study enrolled 215 women in three groups: RA patients refractory to standardized therapy (n = 51); RA patients at complete remission phase (n = 60); and healthy controls (n = 104). CAG and GGC repeat lengths were determined by automated fluorescence-based DNA fragment-sizing method. Demographic data, allele lengths, allele distribution, and zygosity status of CAG/GGC repeats were assessed for the three groups. Refractory RA patients tend to have a significantly younger onset age of RA and more elevated erythrocyte sedimentation rates than do remission RA patients. Mean and median values of CAG and GGC repeat lengths are similar in both RA and control patients. However, RA patients harboring any long CAG alleles with more than 23 repeats had an increased risk of a refractory course, whereas differences in risk were not observed between these patients and RA subtypes harboring any long GGC alleles with more than 16 repeats. In addition, the homozygous frequency of CAG but not GGC alleles was lower in refractory RA than in remission RA patients or in controls (p = 0.042). Neither CAG nor GGC repeat lengths had a significant relationship with rheumatoid factor reactivity. Our observations indicate that short CAG repeats of the AR gene with higher transactivation activity may have protective effects against refractory course of RA development and that homozygous frequency of CAG alleles may be involved in the disease remission subtype. In contrast, lack of association of GGC polymorphism and RA was also observed. Together, these data imply that CAG but not GGC alleles in the AR polymorphism may play an important role in modulating the disease pattern of RA among Taiwanese women.
Literatur
1.
Zurück zum Zitat Oliver JE, Worthington J, Silman AJ (2006) Genetic epidemiology of rheumatoid arthritis. Curr Opin Rheumatol 18:141–146CrossRefPubMed Oliver JE, Worthington J, Silman AJ (2006) Genetic epidemiology of rheumatoid arthritis. Curr Opin Rheumatol 18:141–146CrossRefPubMed
2.
3.
Zurück zum Zitat Ansar Ahmed S, Penhale WJ, Talal N (1985) Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action. Am J Pathol 121:531–551PubMedPubMedCentral Ansar Ahmed S, Penhale WJ, Talal N (1985) Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action. Am J Pathol 121:531–551PubMedPubMedCentral
4.
Zurück zum Zitat Tanriverdi F, Silveira LF, MacColl GS, Bouloux PM (2003) The hypothalamic-pituitary-gonadal axis: immune function and autoimmunity. J Endocrinol 176:293–304CrossRefPubMed Tanriverdi F, Silveira LF, MacColl GS, Bouloux PM (2003) The hypothalamic-pituitary-gonadal axis: immune function and autoimmunity. J Endocrinol 176:293–304CrossRefPubMed
5.
Zurück zum Zitat Cutolo M, Castagnetta L (1996) Immunomodulatory mechanisms mediated by sex hormones in rheumatoid arthritis. Ann N Y Acad Sci 784:237–251CrossRefPubMed Cutolo M, Castagnetta L (1996) Immunomodulatory mechanisms mediated by sex hormones in rheumatoid arthritis. Ann N Y Acad Sci 784:237–251CrossRefPubMed
6.
Zurück zum Zitat Masi AT, Chatterton RT, Aldag JC (1999) Perturbations of hypothalamic-pituitary-gonadal axis and adrenal androgen functions in rheumatoid arthritis: an odyssey of hormonal relationships to the disease. Ann N Y Acad Sci 876:53–63CrossRefPubMed Masi AT, Chatterton RT, Aldag JC (1999) Perturbations of hypothalamic-pituitary-gonadal axis and adrenal androgen functions in rheumatoid arthritis: an odyssey of hormonal relationships to the disease. Ann N Y Acad Sci 876:53–63CrossRefPubMed
7.
Zurück zum Zitat Masi AT, Feigenbaum SL, Chatterton RT (1995) Hormonal and pregnancy relationships to rheumatoid arthritis: convergent effects with immunological and microvascular systems. Semin Arthritis Rheum 25:1–27CrossRefPubMed Masi AT, Feigenbaum SL, Chatterton RT (1995) Hormonal and pregnancy relationships to rheumatoid arthritis: convergent effects with immunological and microvascular systems. Semin Arthritis Rheum 25:1–27CrossRefPubMed
8.
9.
Zurück zum Zitat Pope JE, Joneja M, Hong P (2002) Anti-androgen treatment of prostatic carcinoma may be a risk factor for development of rheumatoid arthritis. J Rheumatol 29:2459–2462PubMed Pope JE, Joneja M, Hong P (2002) Anti-androgen treatment of prostatic carcinoma may be a risk factor for development of rheumatoid arthritis. J Rheumatol 29:2459–2462PubMed
10.
Zurück zum Zitat Booji A, Biewenga-Booji CM, Huber-Bruning O, Cornelis C, Jacobs JW, Bijlsma JW (1996) Androgens as adjuvant treatment in postmenopausal female patients with rheumatoid arthritis. Ann Rheum Dis 55:811–886CrossRefPubMedPubMedCentral Booji A, Biewenga-Booji CM, Huber-Bruning O, Cornelis C, Jacobs JW, Bijlsma JW (1996) Androgens as adjuvant treatment in postmenopausal female patients with rheumatoid arthritis. Ann Rheum Dis 55:811–886CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Khalkhali EZ, Moore TL, Hendrix MJ (1998) Reduced levels of testosterone and dehydroepiandrosterone sulphate in the serum and synovial fluid of juvenile rheumatoid arthritis patients correlates with disease severity. Clin Exp Rheumatol 16:753–756 Khalkhali EZ, Moore TL, Hendrix MJ (1998) Reduced levels of testosterone and dehydroepiandrosterone sulphate in the serum and synovial fluid of juvenile rheumatoid arthritis patients correlates with disease severity. Clin Exp Rheumatol 16:753–756
12.
Zurück zum Zitat Hedman M, Nilsson E, de la Torre B (1992) Low blood and synovial fluid levels of sulpho-conjugated steroids in rheumatoid arthritis. Clin Exp Rheumatol 10:25–30PubMed Hedman M, Nilsson E, de la Torre B (1992) Low blood and synovial fluid levels of sulpho-conjugated steroids in rheumatoid arthritis. Clin Exp Rheumatol 10:25–30PubMed
13.
Zurück zum Zitat Tengstrand B, Carlstrom K, Fellander TL, Hafstrom I (2003) Abnormal levels of serum dehydroepiandrosterone, estrone, and estradiol in men with rheumatoid arthritis: high correlation between serum estradiol and current degree of inflammation. J Rheumatol 30:2338–2343PubMed Tengstrand B, Carlstrom K, Fellander TL, Hafstrom I (2003) Abnormal levels of serum dehydroepiandrosterone, estrone, and estradiol in men with rheumatoid arthritis: high correlation between serum estradiol and current degree of inflammation. J Rheumatol 30:2338–2343PubMed
14.
Zurück zum Zitat Chang CS, Kokontis J, Liao ST (1988) Molecular cloning of human and rat complementary DNA encoding androgen receptors. Science 240:324–326CrossRefPubMed Chang CS, Kokontis J, Liao ST (1988) Molecular cloning of human and rat complementary DNA encoding androgen receptors. Science 240:324–326CrossRefPubMed
15.
Zurück zum Zitat Lubahn DB, Joseph DR, Sullivan PM, Willard HF, French FS, Wilson EM (1988) Cloning of human androgen receptor complementary DNA and localization to the X chromosome. Science 240:327–330CrossRefPubMed Lubahn DB, Joseph DR, Sullivan PM, Willard HF, French FS, Wilson EM (1988) Cloning of human androgen receptor complementary DNA and localization to the X chromosome. Science 240:327–330CrossRefPubMed
16.
Zurück zum Zitat Chamberlain NL, Driver ED, Miesfeld RL (1994) The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 22:3181–3186CrossRefPubMedPubMedCentral Chamberlain NL, Driver ED, Miesfeld RL (1994) The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 22:3181–3186CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Choong CS, Kemppainen JA, Zhou ZX, Wilson EM (1996) Reduced androgen receptor gene expression with first exon CAG repeat expansion. Mol Endocrinol 10:1527–1535PubMed Choong CS, Kemppainen JA, Zhou ZX, Wilson EM (1996) Reduced androgen receptor gene expression with first exon CAG repeat expansion. Mol Endocrinol 10:1527–1535PubMed
18.
Zurück zum Zitat Ding D, Xu L, Menon M, Reddy GPV, Barrack ER (2005) Effect of GGC (glycine) repeat length polymorphism in the human androgen receptor on androgen action. Prostate 62:133–139CrossRefPubMed Ding D, Xu L, Menon M, Reddy GPV, Barrack ER (2005) Effect of GGC (glycine) repeat length polymorphism in the human androgen receptor on androgen action. Prostate 62:133–139CrossRefPubMed
19.
Zurück zum Zitat Doyu M, Sobue G, Mukai E, Kachi T, Yasuda T, Mitsuma T, Takahashi A (1992) Severity of X-linked recessive bulbospinal neuronopathy correlates with size of the tandem CAG repeat in androgen receptor gene. Ann Neurol 32:707–710CrossRefPubMed Doyu M, Sobue G, Mukai E, Kachi T, Yasuda T, Mitsuma T, Takahashi A (1992) Severity of X-linked recessive bulbospinal neuronopathy correlates with size of the tandem CAG repeat in androgen receptor gene. Ann Neurol 32:707–710CrossRefPubMed
20.
Zurück zum Zitat Alevizaki M, Cimponeriu AT, Garofallaki M, Sarika HL, Alevizaki CC, Papamichael C, Philippou G, Anastasiou EA, Lekakis JP, Mavrikakis M (2003) The androgen receptor gene CAG polymorphism is associated with the severity of coronary artery disease in men. Clin Endocrinol 59:749–755CrossRef Alevizaki M, Cimponeriu AT, Garofallaki M, Sarika HL, Alevizaki CC, Papamichael C, Philippou G, Anastasiou EA, Lekakis JP, Mavrikakis M (2003) The androgen receptor gene CAG polymorphism is associated with the severity of coronary artery disease in men. Clin Endocrinol 59:749–755CrossRef
21.
Zurück zum Zitat Westberg L, Baghaei F, Rosmond R, Hellstrand M, Landen M, Jansson M, Holm G, Bjorntorp P, Eriksson E (2001) Polymorphisms of the androgen receptor gene and the estrogen receptor beta gene are associated with androgen levels in women. J Clin Endocrinol Metab 86:2562–2568PubMed Westberg L, Baghaei F, Rosmond R, Hellstrand M, Landen M, Jansson M, Holm G, Bjorntorp P, Eriksson E (2001) Polymorphisms of the androgen receptor gene and the estrogen receptor beta gene are associated with androgen levels in women. J Clin Endocrinol Metab 86:2562–2568PubMed
22.
Zurück zum Zitat Kawasaki T, Ushiyama T, Ueyama H, Inoue K, Mori K, Ohkubo I, Hukuda S (1999) Polymorphic CAG repeats of the androgen receptor gene and rheumatoid arthritis. Ann Rheum Dis 58:500–502CrossRefPubMedPubMedCentral Kawasaki T, Ushiyama T, Ueyama H, Inoue K, Mori K, Ohkubo I, Hukuda S (1999) Polymorphic CAG repeats of the androgen receptor gene and rheumatoid arthritis. Ann Rheum Dis 58:500–502CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Lo SF, Huang CM, Tsai CH, Chen WC, Lai CC, Tsai Y, Tsai FJ (2006) Androgen receptor gene polymorphism and rheumatoid arthritis in Taiwan. Clin Exp Rheumatol 24:209–210PubMed Lo SF, Huang CM, Tsai CH, Chen WC, Lai CC, Tsai Y, Tsai FJ (2006) Androgen receptor gene polymorphism and rheumatoid arthritis in Taiwan. Clin Exp Rheumatol 24:209–210PubMed
24.
Zurück zum Zitat Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324CrossRefPubMed Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324CrossRefPubMed
25.
Zurück zum Zitat National Institute for Clinical Excellence. Guidance on the use of etanercept and infliximab for rheumatoid arthritis. NICE Technology Appraisal Guidance No. 36. London: National Institute for Clinical Excellence. [Internet. Accessed 2002 March]. Available from http://www.nice.org.uk/pdf/RA-PDF.pdf National Institute for Clinical Excellence. Guidance on the use of etanercept and infliximab for rheumatoid arthritis. NICE Technology Appraisal Guidance No. 36. London: National Institute for Clinical Excellence. [Internet. Accessed 2002 March]. Available from http://​www.​nice.​org.​uk/​pdf/​RA-PDF.​pdf
26.
Zurück zum Zitat Ledingham J., Deighton C. on behalf of the British Society for Rheumatology Standards, Guidelines and Audit Working Group (2005) Update on the British Society for Rheumatology guidelines for prescribing TNF-α blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001). Rheumatology 44:157–163CrossRefPubMed Ledingham J., Deighton C. on behalf of the British Society for Rheumatology Standards, Guidelines and Audit Working Group (2005) Update on the British Society for Rheumatology guidelines for prescribing TNF-α blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001). Rheumatology 44:157–163CrossRefPubMed
27.
Zurück zum Zitat Prevoo MLL, van’t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LBA, van Riel PLCM (1995) Modified disease activity scores that include twenty-eight-joint counts. Arthritis Rheum 38:44–48CrossRefPubMed Prevoo MLL, van’t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LBA, van Riel PLCM (1995) Modified disease activity scores that include twenty-eight-joint counts. Arthritis Rheum 38:44–48CrossRefPubMed
28.
Zurück zum Zitat Pinals RS, Masi AT, Larsen RA (1981) Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 24:1308–1315CrossRefPubMed Pinals RS, Masi AT, Larsen RA (1981) Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 24:1308–1315CrossRefPubMed
29.
Zurück zum Zitat Irvine RA, Yu MC, Ross RK, Coetzee GA (1995) The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res 55:1937–1940PubMed Irvine RA, Yu MC, Ross RK, Coetzee GA (1995) The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res 55:1937–1940PubMed
30.
Zurück zum Zitat Spurdle AB, Dite GS, Chen X, Mayne CJ, Southey MC, Batten LE, Chy H, Trute L, McCredie MR, Giles GG, Armes J, Venter DJ, Hopper JL, Chenevix-Trench G (1999) Androgen receptor exon 1 CAG repeat length and breast cancer in women before age forty years. J Natl Cancer Inst (Bethesda) 91:961–966CrossRef Spurdle AB, Dite GS, Chen X, Mayne CJ, Southey MC, Batten LE, Chy H, Trute L, McCredie MR, Giles GG, Armes J, Venter DJ, Hopper JL, Chenevix-Trench G (1999) Androgen receptor exon 1 CAG repeat length and breast cancer in women before age forty years. J Natl Cancer Inst (Bethesda) 91:961–966CrossRef
31.
Zurück zum Zitat Rebbeck TR, Kantoff PW, Krithivas K, Neuhausen S, Blackwood MA, Godwin AK, Daly MB, Narod SA, Garber JE, Lynch HT, Weber BL, Brown M (1999) Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat. Am J Hum Genet 64:1371–1377CrossRefPubMedPubMedCentral Rebbeck TR, Kantoff PW, Krithivas K, Neuhausen S, Blackwood MA, Godwin AK, Daly MB, Narod SA, Garber JE, Lynch HT, Weber BL, Brown M (1999) Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat. Am J Hum Genet 64:1371–1377CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Yeh SH, Chang CF, Shau WY, Chen YW, Hsu HC, Lee PH, Chen DS, Chen PJ (2002) Dominance of functional androgen receptor allele with longer CAG repeat in hepatitis B virus-related female hepatocarcinogenesis. Cancer Res 62:4346–4351PubMed Yeh SH, Chang CF, Shau WY, Chen YW, Hsu HC, Lee PH, Chen DS, Chen PJ (2002) Dominance of functional androgen receptor allele with longer CAG repeat in hepatitis B virus-related female hepatocarcinogenesis. Cancer Res 62:4346–4351PubMed
33.
Zurück zum Zitat Sasaki M, Kaneuchi M, Sakuragi N, Fujimoto S, Carroll PR, Dahiya R (2003) The polyglycine and polyglutamine repeats in the androgen receptor gene in Japanese and Caucasian populations. Biochem Biophys Res Commun 312:1244–1247CrossRefPubMed Sasaki M, Kaneuchi M, Sakuragi N, Fujimoto S, Carroll PR, Dahiya R (2003) The polyglycine and polyglutamine repeats in the androgen receptor gene in Japanese and Caucasian populations. Biochem Biophys Res Commun 312:1244–1247CrossRefPubMed
34.
Zurück zum Zitat Fujii K, Okiura T, Nishimura K, Orimoto C, Nishimukai H (2003) Short tandem repeat typing in exon 1 of the androgen receptor gene. Leg Med (Tokyo) 5(Suppl 1):201–203CrossRef Fujii K, Okiura T, Nishimura K, Orimoto C, Nishimukai H (2003) Short tandem repeat typing in exon 1 of the androgen receptor gene. Leg Med (Tokyo) 5(Suppl 1):201–203CrossRef
35.
Zurück zum Zitat Kang HY, Tsai MY, Chang C, Huang KE (2003) Mechanisms and clinical relevance of androgens and androgen receptor actions. Chang Gung Med J 26:388–402PubMed Kang HY, Tsai MY, Chang C, Huang KE (2003) Mechanisms and clinical relevance of androgens and androgen receptor actions. Chang Gung Med J 26:388–402PubMed
36.
Zurück zum Zitat Janne OA, Palvimo JJ, Kallio P, Mehto M (1993) Androgen receptor and mechanism of androgen action. Ann Med 25:83–89CrossRefPubMed Janne OA, Palvimo JJ, Kallio P, Mehto M (1993) Androgen receptor and mechanism of androgen action. Ann Med 25:83–89CrossRefPubMed
37.
Zurück zum Zitat Cutolo M, Accardo S, Villaggio B, Clerico P, Indiveri F, Carruba G, Fecarotta E, Castagnetta L (1992) Evidence for the presence of androgen receptors in the synovial tissue of rheumatoid arthritis patients and healthy controls. Arthritis Rheum 35:1007–1015CrossRefPubMed Cutolo M, Accardo S, Villaggio B, Clerico P, Indiveri F, Carruba G, Fecarotta E, Castagnetta L (1992) Evidence for the presence of androgen receptors in the synovial tissue of rheumatoid arthritis patients and healthy controls. Arthritis Rheum 35:1007–1015CrossRefPubMed
38.
Zurück zum Zitat Ishizuka M, Hatori M, Suzuki T, Miki Y, Darnel AD, Tazawa C, Sawai T, Uzuki M, Tanaka Y, Kokubun S, Sasano H (2004) Sex steroid receptors in rheumatoid arthritis. Clin Sci (Lond) 106:293–300CrossRef Ishizuka M, Hatori M, Suzuki T, Miki Y, Darnel AD, Tazawa C, Sawai T, Uzuki M, Tanaka Y, Kokubun S, Sasano H (2004) Sex steroid receptors in rheumatoid arthritis. Clin Sci (Lond) 106:293–300CrossRef
39.
Zurück zum Zitat Krithivas K, Yurgalevitch SM, Mohr BA, Wilcox CJ, Batter SJ, Brown M, Longcope C, McKinlay JB, Kantoff PW (1999) Evidence that the CAG repeat in the androgen receptor gene is associated with the age-related decline in serum androgen levels in men. J Endocrinol 162:137–142CrossRefPubMed Krithivas K, Yurgalevitch SM, Mohr BA, Wilcox CJ, Batter SJ, Brown M, Longcope C, McKinlay JB, Kantoff PW (1999) Evidence that the CAG repeat in the androgen receptor gene is associated with the age-related decline in serum androgen levels in men. J Endocrinol 162:137–142CrossRefPubMed
40.
Zurück zum Zitat Giovannucci E, Stampfer MJ, Krithivas K, Brown M, Dahl D, Brufsky A, Talcott J, Hennekens CH, Kantoff PW (1997) The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci U S A 94:3320–3323CrossRefPubMedPubMedCentral Giovannucci E, Stampfer MJ, Krithivas K, Brown M, Dahl D, Brufsky A, Talcott J, Hennekens CH, Kantoff PW (1997) The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci U S A 94:3320–3323CrossRefPubMedPubMedCentral
41.
Zurück zum Zitat Sasaki M, Dahiya R, Fujimoto S, Ishikawa M, Oshimura M (2000) The expansion of the CAG repeat in exon 1 of the human androgen receptor gene is associated with uterine endometrial carcinoma. Mol Carcinog 27:237–244CrossRefPubMed Sasaki M, Dahiya R, Fujimoto S, Ishikawa M, Oshimura M (2000) The expansion of the CAG repeat in exon 1 of the human androgen receptor gene is associated with uterine endometrial carcinoma. Mol Carcinog 27:237–244CrossRefPubMed
42.
Zurück zum Zitat Sasaki M, Karube A, Karube Y, Watari M, Sakuragi N, Fujimoto S, Dahiya R (2005) GGC and StuI polymorphism on the androgen receptor gene in endometrial cancer patients. Biochem Biophys Res Commun 329:100–104CrossRefPubMed Sasaki M, Karube A, Karube Y, Watari M, Sakuragi N, Fujimoto S, Dahiya R (2005) GGC and StuI polymorphism on the androgen receptor gene in endometrial cancer patients. Biochem Biophys Res Commun 329:100–104CrossRefPubMed
43.
Zurück zum Zitat Dietzsch E, Laubscher R, Parker MI (2003) Esophageal cancer risk in relation to GGC and CAG trinucleotide repeat lengths in the androgen receptor gene. Int J Cancer 107:38–45CrossRefPubMed Dietzsch E, Laubscher R, Parker MI (2003) Esophageal cancer risk in relation to GGC and CAG trinucleotide repeat lengths in the androgen receptor gene. Int J Cancer 107:38–45CrossRefPubMed
44.
Zurück zum Zitat Suter NM, Malone KE, Daling JR, Doody DR, Ostrander EA (2003) Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case-control study of young women. Cancer Epidemiol Biomark Prev 12:127–135 Suter NM, Malone KE, Daling JR, Doody DR, Ostrander EA (2003) Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case-control study of young women. Cancer Epidemiol Biomark Prev 12:127–135
45.
Zurück zum Zitat Schmidt BJ, Greenberg CR, Allingham-Hawkins DJ, Spriggs EL (2002) Expression of X-linked bulbospinal muscular atrophy (Kennedy disease) in two homozygous women. Neurology 59:770–772CrossRefPubMed Schmidt BJ, Greenberg CR, Allingham-Hawkins DJ, Spriggs EL (2002) Expression of X-linked bulbospinal muscular atrophy (Kennedy disease) in two homozygous women. Neurology 59:770–772CrossRefPubMed
46.
Zurück zum Zitat Racchi O, Mangerini R, Rapezzi D, Rolfo M, Gaetani GF, Ferraris AM (1998) X chromosome inactivation patterns in normal females. Blood Cells Mol Diseases 24:439–447CrossRef Racchi O, Mangerini R, Rapezzi D, Rolfo M, Gaetani GF, Ferraris AM (1998) X chromosome inactivation patterns in normal females. Blood Cells Mol Diseases 24:439–447CrossRef
Metadaten
Titel
Association of tri-nucleotide (CAG and GGC) repeat polymorphism of androgen receptor gene in Taiwanese women with refractory or remission rheumatoid arthritis
verfasst von
S. F. Yu
T. T. Cheng
Y. H. Hsu
H. M. Lai
Y. C. Chen
C. K. Chiu
K. M. Lin
C. Chang
C. J. Chen
H. Y. Kang
Publikationsdatum
01.12.2007
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 12/2007
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-007-0616-z

Weitere Artikel der Ausgabe 12/2007

Clinical Rheumatology 12/2007 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hodgkin Lymphom: BrECADD-Regime übertrifft die Erwartungen

05.06.2024 ASCO 2024 Kongressbericht

Das Kombinationsregime BrECADD mit Brentuximab vedotin ermöglichte in der Studie HD21 beim fortgeschrittenen klassischen Hodgkin-Lymphom eine unerwartet hohe progressionsfreie Überlebensrate von 94,3% nach vier Jahren. Gleichzeitig war das Regime besser tolerabel als der bisherige Standard eBEACOPP.

Antikörper-Drug-Konjugat verdoppelt PFS bei Multiplem Myelom

05.06.2024 ASCO 2024 Nachrichten

Zwei Phase-3-Studien deuten auf erhebliche Vorteile des Antikörper-Wirkstoff-Konjugats Belantamab-Mafodotin bei vorbehandelten Personen mit Multiplem Myelom: Im Vergleich mit einer Standard-Tripeltherapie wurde das progressionsfreie Überleben teilweise mehr als verdoppelt.

Neuer TKI gegen CML: Höhere Wirksamkeit, seltener Nebenwirkungen

05.06.2024 Chronische myeloische Leukämie Nachrichten

Der Tyrosinkinasehemmer (TKI) Asciminib ist älteren Vertretern dieser Gruppe bei CML offenbar überlegen: Personen mit frisch diagnostizierter CML entwickelten damit in einer Phase-3-Studie häufiger eine gut molekulare Response, aber seltener ernste Nebenwirkungen.

Hereditäres Angioödem: Tablette könnte Akuttherapie erleichtern

05.06.2024 Hereditäres Angioödem Nachrichten

Medikamente zur Bedarfstherapie bei hereditärem Angioödem sind bisher nur als Injektionen und Infusionen verfügbar. Der Arzneistoff Sebetralstat kann oral verabreicht werden und liefert vielversprechende Daten.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.